I first warned readers about these stocks last month. Since then, many of them have fallen — including one that fell 25% and another 27%. Now, recent actions by some of the companies in this industry have solidified my opinion. I’m still convinced millions of investors are… Read More

Sometimes it takes guts to be an income investor. A few weeks ago, the S&P 500 closed above 1,400 for the first time since May 2008, before the Lehman Brothers collapse led off the financial crisis. In total, the index has… Read More

Warren Buffett is back in the news, and not on the opinion pages about the so-called “Buffett Rule” that would subject high-income earners to additional taxation. Buffett is on Page One because he has prostate cancer. It’s Stage One, easily treatable… Read More

There’s an old saying on Wall Street that investors should look to the income statement for upside and the balance sheet for downside protection. But for mining and energy stocks, this axiom has been spun on its… Read More

In 1994, the season finale of NBC’s popular sitcom, “Friends,” garnered an estimated 52.5 million viewers. Today, “The Office,” one of NBC’s most popular comedies, is lucky to have about 2.5 million viewers each week. The steady demise of network television has been a boon for cable… Read More

Investors are often faced with a clear conundrum — what to do with a stock that holds great long-term promise and stumbling near-term execution. That question has been vexing me ever since I added shares of Cree Inc. (Nasdaq: CREE) to my $100,000 Real-Money Portfolio in early January and… Read More

The greatest demographic trend affecting the United States today is the aging of the baby-boomer generation. Many of the baby boomers (those born between 1946 and 1964) are beginning to retire. In fact, starting this year it is estimated that 10,000 baby boomers will retire every day. This means there… Read More

Randal J. Kirk is beside himself right now. The legendary biotech investor, who is now worth more than $2 billion, made a rare misstep by plunking down $14 million (at $10.61 a share) on Halozyme Therapeutics (Nasdaq: HALO) in February, only to see that investment lose a quarter of its… Read More

Last year, the Dow Jones Utility Average (DJU) was on a tear. At least for a boring utility index, it was. The index returned 15% before dividends, its best annual performance in four years.   Throw dividends in, and we’re probably… Read More

With just a quick glance, the whole “invest in India” craze appears to have run its course. India’s stock market, the Bombay Stock Exchange Sensex Index, rallied more than 200% between March of 2009 and late 2010. Read More